[New paper] Mutations that confer EGFR-TKI resistance

We published a new paper in Lung Cancer.

In this collaborative study with Prof. Byung-Chul Cho (Severance Hospital, Dept. of Internal Medicine) Sora Kim and Sangwoo Kim analyzed genomic profiles of lung cancer patients who had a first-line EGFR-TKI (EGFR Tyrosine Kinase Inhibitor) and developed a resistant relapse to find the genomic differences between the groups. We found a new EGFR mutation (EGFR p.T263P) confers resistance to EGFR-TKI.

"Next-generation sequencing reveals novel resistance mechanisms and molecular heterogeneity in EGFR-mutant non-small cell lung cancer with acquired resistance to EGFR-TKIs", Lung Cancer 2017, 113:106-114

Featured Posts
Recent Posts
Search By Tags
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

서울특별시 서대문구 연세로 50-1, 연세대학교 의과대학 신관 613호

#613 Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, South Korea  


02-2228-2589 (inside Korea)

  • w-facebook
  • Twitter Clean
  • w-googleplus
  • W-Pinterest

© Since 2014 Translational Genome Informatics Laboratory,

Yonsei University College of Medicine.

Proudly created with Wix.com